Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure.
Dimiou S, Lopes RM, Kubajewska I, Mellor RD, Schlosser CS, Shet MS, Huang H, Akcan O, Whiteside GT, Schätzlein AG, Uchegbu IF.
Dimiou S, et al. Among authors: schlosser cs.
Int J Pharm. 2022 Apr 25;618:121658. doi: 10.1016/j.ijpharm.2022.121658. Epub 2022 Mar 12.
Int J Pharm. 2022.
PMID: 35292396
Free article.